Difficulty: Medium
Average Score: 93%
Practice
Isoniazid:
Correct answer
A
Rationale
Isoniazid undergoes acetylation by N-acetyltransferase in the liver (A), a polymorphic process affecting its metabolism (fast vs. slow acetylators), influencing toxicity and dosing. It's used throughout the six-month TB regimen in the UK (initial 2 months with rifampicin, pyrazinamide, ethambutol, then 4 months with rifampicin), not just initially (B is incorrect). It's readily absorbed from the gut (C), achieving high bioavailability. It diffuses into the CSF (D is incorrect), critical for TB meningitis treatment. It's not contraindicated in children under 10 (original E). Isoniazid's bactericidal action on Mycobacterium tuberculosis, targeting mycolic acid synthesis, is foundational in TB therapy, though peripheral neuropathy (preventable with pyridoxine) is a key side effect.